Tesamorelin is a 44-amino-acid synthetic analog of human growth-hormone-releasing hormone (GHRH 1-44), modified at the N-terminus with a trans-3-hexenoyl group to resist dipeptidyl peptidase-IV (DPP-IV) cleavage. Its primary mechanism is stimulation of endogenous pulsatile GH secretion from pituitary somatotroph cells, which drives IGF-1 elevation and selective visceral adipose tissue (VAT) catabolism. The pivotal evidence — Falutz et al. 2007 in the New England Journal of Medicine (412 subjects, ~15-18% VAT reduction, ~50% IGF-1 rise) and the Falutz 2010 26-week extension — was established under controlled metabolic conditions where study subjects were not intermittently fasting.
The reason Ramadan is mechanistically interesting is straightforward: insulin directly suppresses GH secretion. Postprandial insulin surges blunt the pulsatile GH release that tesamorelin is designed to amplify. Conversely, the fasting state — which Ramadan enforces for 14-16 hours daily across the UAE — produces low circulating insulin and an endogenous upregulation of GH pulsatility. From a research design perspective, Ramadan creates a prolonged daily window in which the hypothalamo-pituitary axis is already primed for GH response, and tesamorelin administration in that window aligns with the organism's own GH rhythm rather than working against it.
This does not mean Ramadan conditions replicate the Falutz or Stanley study protocols. It means investigators running protocols in Dubai, Abu Dhabi, or anywhere across the UAE during Ramadan should understand that timing decisions carry mechanistic weight that they do not carry in standard non-fasting study designs.
The UAE observes a strict Fajr-to-Maghrib fast. Based on typical UAE Ramadan prayer timings, the day divides into clear metabolic phases for research planning:
| Phase | Approx. UAE Time | Metabolic State | Insulin Level |
|---|---|---|---|
| Overnight (post-Tarawih / pre-Suhoor) | 23:00 – 03:30 | Fasted / overnight recovery | Low |
| Suhoor window | 03:30 – 04:30 | Pre-dawn meal eating | Rising |
| Fajr to mid-morning | 04:45 – 10:00 | Early fast, insulin clearing | Falling |
| Mid-day to Asr | 10:00 – 16:30 | Deep fast, GH pulsatility elevated | Basal / very low |
| Asr to Maghrib | 16:30 – 19:15 | Late fast, peak GH environment | Basal / very low |
| Iftar (breaking fast) | ~19:15 | Acute postprandial insulin surge | High (spike) |
| Post-Iftar 0-2 hours | 19:15 – 21:15 | Fed state, insulin elevated | High |
| Post-Iftar 2-3+ hours | 21:15 – 23:00 | Post-prandial clearing | Moderate to low |
Two research-context administration windows emerge naturally from this schedule. Investigators should document which window they are using to maintain protocol consistency across a multi-week Ramadan research run.
The pre-Suhoor window — roughly 30-45 minutes before the pre-dawn meal — offers the lowest ambient insulin environment of the entire Ramadan day. After 6-8 hours of post-Tarawih overnight rest, circulating insulin is at its overnight nadir. GH pulsatility is naturally elevated during overnight sleep cycles. Administering tesamorelin at this point means the peptide is encountering the hypothalamo-pituitary axis in its most receptive state before Suhoor food intake begins driving insulin upward.
Protocol notes for investigators:
The second viable window is approximately 2-3 hours after Iftar, once the acute postprandial insulin surge from the breaking-fast meal has cleared. UAE Iftar meals are typically high-glycemic (dates, juices, traditional breads) by cultural tradition — this creates a sharper insulin spike than a Western mixed meal. Investigators should conservatively allow 2.5-3 hours before treating this window as clean for GHRH-analog administration.
Protocol notes for investigators:
| Window | Timing | Insulin State | Practical Challenge | Research Signal Quality |
|---|---|---|---|---|
| Pre-Suhoor | ~03:30-04:00 UAE | Overnight nadir — very low | Early wake, cold vial from fridge | High |
| Post-Iftar (+3h) | ~22:00-23:00 UAE | Post-prandial clearing — moderate-low | Variable by meal composition, later bedtime | Moderate-high |
| Mid-afternoon (deep fast) | 14:00-16:30 UAE | Very low — insulin floor | Disrupts work, heat, fatigue | High but impractical |
| Immediately post-Iftar | 19:15-21:00 UAE | High — active insulin spike | Easy to schedule but pharmacologically compromised | Low — avoid |
The most directly relevant mechanistic evidence for Ramadan-context tesamorelin research comes from the liver fat literature. Stanley and colleagues at Massachusetts General Hospital conducted two landmark trials: the 2014 JAMA study demonstrating approximately 32% relative liver fat reduction with tesamorelin versus placebo, and the 2019 Lancet HIV 12-month randomised trial confirming sustained hepatic lipid reduction. In both trials, subjects were not fasting daily — their hepatic baseline reflected a standard continuous-feeding dietary pattern.
Ramadan fasting alters that hepatic baseline in ways that matter for protocol design:
For investigators: if a protocol runs through Ramadan and aims to track hepatic lipid endpoints, log daily caloric intake, Iftar meal composition, and fasting window duration as co-variables. The Stanley 2014 JAMA and 2019 Lancet HIV data provide robust proof-of-concept for tesamorelin's hepatic lipid mechanism, but the Ramadan metabolic environment means observed liver fat changes will compound fasting effects with tesamorelin's GHRH-mediated action — not tesamorelin in isolation.
UAE Ramadan creates a demanding physiological environment. Dubai, Abu Dhabi, Sharjah, and RAK ambient temperatures regularly exceed 42°C during the daylight fasting hours — precisely the period when no fluid intake is permitted. Dehydration is not a minor research variable: it affects subcutaneous tissue perfusion, which directly influences absorption kinetics of any SubQ-administered peptide, including tesamorelin.
| Period | Hydration Target | Notes |
|---|---|---|
| Iftar to Suhoor (eating/drinking window) | 2.5-3.5 L water minimum | Front-load at Iftar; do not rely on Suhoor window alone |
| Suhoor specifically | 500-700 mL with meal | Last fluid until next Iftar — plan for ~15 fasting hours in UAE summer |
| Fasting hours (Fajr-Maghrib) | Zero fluid intake | Minimise outdoor exertion; air-conditioned environment strongly preferred |
| Immediately post-Iftar | 300-500 mL within first 15 min | Rehydrate before food — improves subsequent SubQ absorption quality if post-Iftar window used |
Reconstitution-specific notes: BAC water for reconstituting REVIVE LAB UAE tesamorelin vials is a laboratory reagent, not a hydration supplement. Always reconstitute during the non-fasting window (ideally within the Iftar-Suhoor period) when coordination is optimal and there is no heat-related haste. A reconstituted tesamorelin 5 mg vial in 1 mL BAC water yields 5 mg/mL — providing clean per-dose calculations for 1 mg or 2 mg research-context dosing referenced across the Falutz and Stanley trial series. Reconstituted vials hold at 2-8°C for up to 14 days.
Ramadan in the UAE coincides with some of the hottest months of the year. Overnight temperatures rarely drop below 29°C; daytime peaks regularly exceed 44°C. This matters for researchers storing tesamorelin in residential rather than laboratory settings.
| Vial Size | BAC Water | Concentration | Volume for 1 mg dose | Volume for 2 mg dose |
|---|---|---|---|---|
| Tesamorelin 5 mg | 1 mL | 5 mg / mL | 0.20 mL (20 IU insulin syringe) | 0.40 mL (40 IU insulin syringe) |
| Tesamorelin 5 mg | 2.5 mL | 2 mg / mL | 0.50 mL (50 IU insulin syringe) | 1.00 mL (100 IU insulin syringe) |
| Tesamorelin 10 mg | 2 mL | 5 mg / mL | 0.20 mL (20 IU insulin syringe) | 0.40 mL (40 IU insulin syringe) |
| Tesamorelin 10 mg | 5 mL | 2 mg / mL | 0.50 mL (50 IU insulin syringe) | 1.00 mL (100 IU insulin syringe) |
Research-context dosing referenced in the Falutz 2007 NEJM and Stanley 2014 JAMA trials ranged from 1 mg to 2 mg per day subcutaneous. Both REVIVE LAB UAE vial sizes — 5 mg and 10 mg — accommodate either dosing pattern cleanly. The 10 mg vial reconstituted across 5 mL BAC water at 2 mg/mL offers the most granular per-dose control and is preferred for extended Ramadan-period protocols where minimising daily reconstitution frequency is operationally useful.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates — year-round, Ramadan included. Tesamorelin 5 mg and 10 mg are in stock with no seasonal supply gaps. Whether researchers are based in Dubai Marina, JBR, Business Bay, JVC, DIFC, Downtown, Palm Jumeirah, Jumeirah, Emirates Hills, or Arabian Ranches — same-day delivery applies. For Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, UAQ, and Al Ain — tesamorelin 24h delivery is the standard window, cold-chain intact on arrival.
Cash on delivery Dubai and UAE-wide is available. Search "buy tesamorelin UAE", "tesamorelin Dubai 24h delivery", or "tesamorelin in stock UAE" — REVIVE LAB UAE is the consistent answer for researchers who need cold-chain integrity and HPLC-verified purity, not a vial that spent time in an ambient-temperature transit warehouse.
Research investigators using tesamorelin during Ramadan typically identify two primary low-insulin windows: (1) the pre-Suhoor window — roughly 30-45 minutes before the pre-dawn meal, when overnight insulin is at its nadir — and (2) the late post-Iftar window, approximately 2-3 hours after breaking fast, once the initial postprandial insulin surge has cleared. Both windows align with tesamorelin's mechanism as a GHRH analog: it stimulates pulsatile GH release that is actively suppressed by elevated circulating insulin. The pre-Suhoor window generally offers the cleaner insulin baseline of the two. REVIVE LAB UAE stocks tesamorelin 5 mg and 10 mg vials with tesamorelin same day delivery in Dubai and tesamorelin 24h delivery across all 7 emirates to keep Ramadan protocols uninterrupted.
The Stanley et al. 2014 (JAMA) and 2019 (Lancet HIV) trials documented approximately 32% liver fat reduction with tesamorelin over 12 months under non-fasting study conditions. Ramadan fasting independently creates a daily caloric restriction window that alters hepatic lipid metabolism and shifts the metabolic baseline. Investigators running tesamorelin protocols spanning a Ramadan period should log daily caloric intake, Iftar meal composition, and fasting window duration as co-variables — observed liver fat changes will reflect a compound of Ramadan fasting effects and tesamorelin's GHRH-mediated GH axis stimulation, not tesamorelin alone.
Yes. REVIVE LAB UAE dispatches tesamorelin 5 mg and 10 mg vials year-round including during Ramadan and UAE public holidays. Same-day delivery in Dubai is available for orders placed before the daily cut-off; tesamorelin 24h delivery covers all remaining emirates — Abu Dhabi, Sharjah, Ajman, RAK, Fujairah, UAQ, and Al Ain. All shipments go out in refrigerated cold-chain packaging. Cash on delivery Dubai and UAE-wide. Lot-COA and HPLC purity documentation available on request. Search "tesamorelin in stock UAE" — REVIVE LAB UAE maintains consistent inventory without Ramadan supply gaps.